Related Experiment Video

Updated: May 22, 2026

Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Mitochondrial remodeling in cancer metabolism and survival: potential for new therapies

Inês A Barbosa1, Nuno G Machado, Andrew J Skildum

  • 1CNC - Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.

Biochimica Et Biophysica Acta
|May 5, 2012
PubMed

Insights

Mitochondrial alterations are common in cancer, offering unique targets for therapy. This review explores how these changes drive cancer and their potential for new drug development and patient stratification.

Area of Science:

  • Cell Biology
  • Oncology
  • Biochemistry

Background:

  • Mitochondria are vital organelles involved in cellular metabolism and programmed cell death.
  • Mitochondrial genomic, functional, and structural changes are linked to cancer development.
  • These alterations can confer a survival advantage to cancer cells under oncogenic stress.

Purpose of the Study:

  • To review key mitochondrial alterations in tumor cells.
  • To discuss their role in cancer progression and survival.
  • To evaluate their potential for cancer therapy and patient stratification.

Main Methods:

  • Literature review of mitochondrial alterations in cancer.
  • Analysis of the contribution of these alterations to cancer biology.
  • Assessment of therapeutic strategies targeting mitochondrial pathways.

Main Results:

  • Specific mitochondrial alterations provide selective advantages for cancer cell survival and growth.
  • Altered mitochondrial metabolism is a hallmark of many cancers.
  • Mitochondria present promising therapeutic targets for novel cancer treatments.

Conclusions:

  • Targeting cancer cell mitochondria offers a promising avenue for therapeutic intervention.
  • Mitochondrial alterations can serve as biomarkers for cancer patient stratification.
  • Further research into mitochondrial-targeted therapies is warranted for effective cancer treatment.

More Related Videos

Assessment of the Metabolic Profile of Primary Leukemia Cells06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates11:32

Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates

Published on: August 6, 2021

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...